Advertisement

Pediatric Nephrology

, Volume 21, Issue 5, pp 733–736 | Cite as

Ceftriaxone-related hemolysis and acute renal failure

  • Erkan DemirkayaEmail author
  • Abdullah Avni Atay
  • Ugur Musabak
  • Ali Sengul
  • Faysal Gok
Brief Report

Abstract

A 5-year-old girl with no underlying immune deficiency or hematologic disease was treated with a combination of ceftriaxone and ampicilline-sulbactam for pneumonia. On the ninth day of the therapy, she developed oliguria, paleness, malaise, immune hemolytic anemia (IHA) and acute renal failure (ARF). Laboratory studies showed the presence of antibodies against ceftriaxone. Acute interstitial nephritis (AIN) was diagnosed by renal biopsy. The patient’s renal insufficiency was successfully treated with peritoneal dialysis without any complications. The patient recovered without any treatment using steroids or other immunosuppressive agents.

Keywords

Ceftriaxone Immune hemolytic anemia Tubulointerstitial nephritis Acute renal failure Direct antiglobulin test 

References

  1. 1.
    Bell MJ, Stockwell DC, Luban NL, Shirey RS, Shaak L, Ness PM, Wong EC (2005) Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Pediatr Crit Care Med 6(3):363–366CrossRefGoogle Scholar
  2. 2.
    Wells JV, Isbister JP (1991) Hematologic diseases. In: Stites DP, Terr AI (eds) Basic and clinical immunology, 7th edn. Prentice-Hall International, London, 476–491Google Scholar
  3. 3.
    Arndt PA, Leger RM, Garatty G (1999) Serology of antibodies to second and third generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 39:1239–1246CrossRefGoogle Scholar
  4. 4.
    Garatty G, Arndt PA (1998) Positive direct antiglobulin tests and hemolytic anemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic absorption of protein onto red blood cells. Br J Haematol 100:777–7783CrossRefGoogle Scholar
  5. 5.
    Seltsam A, Salama A (2000) Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 26(9):1390–1394CrossRefGoogle Scholar
  6. 6.
    Petz LD (1993) Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 7(4):242–254CrossRefGoogle Scholar
  7. 7.
    Viner Y, Hashkes PJ, Yakubova R, Segal-Kupershmit D, Luder AS (2000) Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia. Pediatr Infect Dis J 19(1):83–85CrossRefGoogle Scholar
  8. 8.
    Mattis LE, Saavedra JM, Shan H, Shirey RS, Powell E, Oliva-Hemker MM (2004) Life-threatening ceftriaxone-induced immune hemolytic anemia in a child with Crohn’s disease. Clin Pediatr (Phila) 43:175–178CrossRefGoogle Scholar
  9. 9.
    Borgna-Pignatti C, Bezzi TM, Reverberi R (1995) Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 14:1116–1117CrossRefGoogle Scholar
  10. 10.
    Meyer O, Hackstein H, Hoppe B, Gobel FJ, Bein G, Salama A (1999) Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 105:1084–1085CrossRefGoogle Scholar
  11. 11.
    Morin JP, Fillastre JP, Olier B (1984) Antibiotic nephrotoxicity. Chemioterapia 3(1):33–40PubMedGoogle Scholar
  12. 12.
    Alon US (2004) Tubulointerstitial nephritis. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, 817–831Google Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Erkan Demirkaya
    • 1
    Email author
  • Abdullah Avni Atay
    • 2
  • Ugur Musabak
    • 3
  • Ali Sengul
    • 3
  • Faysal Gok
    • 1
  1. 1.Department of Pediatric NephrologyGulhane Military Medical AcademyEtlikTurkey
  2. 2.Department of Pediatric HematologyGulhane Military Medical AcademyEtlikTurkey
  3. 3.Department of ImmunologyGulhane Military Medical AcademyEtlikTurkey

Personalised recommendations